DocWire News Editors

DocwireNews

This past Friday, Palantir Technologies was awarded a $7 million, three-year contract by the National Institutes of Health (NIH). Founded by Peter Thiel, the West Coast data analytics company will be using their software platform to gather research data from both private and public sources into one interface, with the ultimate goal being to streamline data analyses.Palantir specializes in creating data platforms for organizations dealing with extremely complex and sensitive data. They have worked with companies in the past perform tasks such as enhancing car and plane safety, pharmaceutical research, and even terrorism defense. The company is based in Palo Alto and has smaller offices in New York, Washington D.C., and even overseas in London and Paris.Specifically, Palantir will be using its technology as a collective platform for the National Center for Advancing Translational Sciences (NCATS) and its similar organizations. NCATS is one of the NIH&rsquo;s 27 Institutes and Centers, and functions to speed new medication and medical technology distribution by better dispersing research data. By integrating Palantir&rsquo;s software, NCATS teams will be able to advance their translational research.With NCATS&rsquo; research data deriving from multiple sources and formats, Palantir&rsquo;s head of biomedical R&amp;D, Andrew Girvin, claims that their company&rsquo;s systems will assist NCATS researchers with comprehension of data that was once fragmented. The signing of this contract not only marks a huge advancement for the NIH, but a government sponsorship for the innovative tech firm as well.&ldquo;NCATS&rsquo; mission is to get more treatments to patients more quickly,&rdquo; said Girvin. &ldquo;By bringing together disparate data into one interface, researchers will soon benefit from greater insights in a fraction of the time. Ultimately, the goal is to help accelerate the discovery of new therapies for cancer and other illnesses.&rdquo;Girvin also claimed that this contract follows up Palantir&rsquo;s previous healthcare work with several cancer centers, drug discovery organizations, and the FDA. &ldquo;In healthcare, the data just happens to be different from the other verticals,&rdquo; he said. &ldquo;We&rsquo;re looking at data from next-generation sequencing, proteomics from mass [spectrometry] instruments, epigenomics, high-throughput drug screening, and then we&rsquo;re looking at each of these sources in the public and private domain, bringing them together to ultimately help people answer questions of a couple flavors, one of which has to do with precision medicine.&rdquo;<blockquote class="twitter-tweet" data-lang="en">
We&rsquo;re deploying our software to help <a href="https://twitter.com/ncats_nih_gov?ref_src=twsrc%5Etfw">@ncats_nih_gov</a> &ldquo;accelerate the discovery of new therapies for cancer and other illnesses.&rdquo; Read more: <a href="https://t.co/kyJXHEaAXt">https://t.co/kyJXHEaAXt</a>
&mdash; Palantir (@PalantirTech) <a href="https://twitter.com/PalantirTech/status/1044270407098994694?ref_src=twsrc%5Etfw">September 24, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Sources: <a href="https://www.apnews.com/38f1e06eb1dd473ba15fae0ef7d32d3f">AP News</a>, <a href="https://www.apnews.com/38f1e06eb1dd473ba15fae0ef7d32d3f">MobiHealthNews</a>

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Latest News

NIH Awards Palantir Technologies with $7 Million Contract for Research Data Simplifying Platform

Future of Medicine

This past Friday, Palantir Technologies was awarded a $7 million, three-year contract by the National Institutes of Health (NIH). Founded by Peter Thiel, the West Coast data ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe